Virtual Medicinal Product (VMP) - Olanzapine embonate 405mg powder and solvent for suspension for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Olanzapine embonate 405mg powder and solvent for suspension for injection vials | Start Date 26-07-2010 | End Date |
| Previous Name | Previous Name Olanzapine pamoate 405mg powder and solvent for suspension for injection vials | Start Date 14-04-2010 |
End Date
|
| Abbreviated Name | Abbreviated Name Olanzapine embonate 405mg inj vials | Start Date 26-07-2010 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Powder and solvent for suspension for injection
- Ontology Form/Route
- suspensioninjection.intramuscular-deep
- Name Basis
- INNM - International Non-proprietary Name (Modified)
Codes
- ATC Code
- N05AH03
- BNF Codes
-
- BNF code 04020200
| Code | Start Date | End Date |
|---|---|---|
| 17038711000001107 | 07-04-2010 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Olanzapine embonate monohydrate | Based on Base Substance | Olanzapine | 405 mg |
Name
Olanzapine embonate monohydrate
Basis of strength description
Based on Base Substance
BOSS
Olanzapine
Strength and UOM (Nmr)
405
Strength and UOM (Dmr)
Parent Products
-
VTMOlanzapine embonate
-
VMP(Current) Olanzapine embonate 405mg powder and...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial | 28552 | Part VIIIA Category C |